CareValidate gives storefronts the clinical pathway to offer doctor-reviewed, prescription-strength treatment for hair loss, entirely online.
Hair loss is one of those patient experiences that's deeply personal, chronically undertreated, and increasingly being addressed online. The DTC hair loss market demonstrated that patients will engage with health content and convert on treatment when the experience is approachable and doesn't require awkward in-person conversations. CareValidate's offering is built on that insight.
Americans affected by androgenetic alopecia. 50M men and 30M women in the U.S. alone
U.S. hair loss treatment market, with DTC telehealth taking a rapidly growing share
Hair loss is a long-term condition, meaning patients who respond to treatment stay on it for years
Hair loss treatment is one of the highest-retention categories in DTC health. Unlike acute conditions, androgenetic alopecia (AGA) is progressive and chronic. Patients who find a protocol that slows or reverses their hair loss have a strong incentive to keep refilling.
For storefronts focused on men's health, hair regrowth pairs naturally with ED: same demographic, same willingness to engage online, same desire for privacy and speed. Together they form a high-retention men's health platform with compounding LTV as patients stay on both protocols long term.
Patient completes questionnaire covering hair loss history, pattern, and health history.
Licensed clinician reviews intake and determines appropriate treatment.
Medication dispensed and shipped on a recurring basis.
If appropriate, provider prescribes from the formulary.
.svg)
| Product / Tier | Offering | Form |
|---|---|---|
| Standard AGA Combo | Finasteride + Topical Minoxidil | OralTopical |
| Oral Minoxidil | Oral Minoxidil | Oral |
| Premium Combo Capsule | Finasteride + Oral Minoxidil | Oral |
| Topical Finasteride | Topical Finasteride | Topical |